NEUROLENTECH GmbH

Only one day to go at the ISSCR 2024 event 🚀 Looking forward to the final day and to learn more about Stem cells! Our team at NEUROLENTECH GmbH is glad to be part of this event and for all the inspiring scientists we got to meet. If you are attending, make sure to connect with our experts: Federico Salaris and Maria Pires. They’ll be more than happy to share insights on how we harness the power of iPSCs for NDD drug discovery 🧠 #isscr2024 #ipsc #iNeurons

🚀 The NEUROLENTECH GmbH team is excited to participate in the ISSCR 2024 event! Join us in Hamburg, Germany, from the 9th to the 13th of July! 🧠 Federico Salaris and Maria Pires will present a poster on Wednesday, July 10th, from 18:45 until 19:45 local time. Find us on poster board 542, we would be happy to answer any questions you have! If you're curious about Neurolentech's journey towards new treatments for epilepsy and neurodevelopmental disorders, come say hi anytime! 👋   Learn more about the event: https://www.isscr2024.org/   Learn more about Neurolentech: www.neurolentech.com   #ISSCR2024 #stemcells #SPiN

🌟Hello from Future Labs Live Basel! We are thrilled to participate in this conference, where the labs of the future are brought into the present. At NEUROLENTECH GmbH, we are committed to making our lab processes smarter, more sustainable, and more efficient. Our Lab Manager, Mellie Pieraks, will be in Basel for the two-day event, eager to help us achieve these goals. If you want to learn more about Neurolentech, don't hesitate to say hi!👋

Exciting news alert! 🚀 NEUROLENTECH GmbH has partnered with Kaerus Bioscience Ltd.! 🧠 Neurolentech's Neurodevelopmental Disorders Drug Discovery platform, together with Kaerus Bioscience's dedication to innovation, will propel advancements in treating genetic neurodevelopmental disorders (NDDs) 💼 Robert H. Ring, CEO of Kaerus Bioscience: "This underscores our commitment to accelerating treatments for neurodevelopmental disorders." 🔬 This collaboration is a major milestone in Neurolentech's mission to revolutionize drug discovery for NDDs, offering invaluable resources for researchers and industry partners. For the official press release follow the link: https://lnkd.in/ddzSq2vw #DrugDiscovery #NeurodevelopmentalDisorders #Partnership

Our CEO, Fiona Nielsen, is the newest guest at the #risingtidepodcast by Systemanova.vc!🎙️ In this episode, Fiona talks about how NEUROLENTECH GmbH is developing new fields of scientific research that will impact the pharmaceutical treatment of Epilepsy, Autism and Neurodevelopmental diseases.🧠💊 Thank you to Systemanova.vc for the the invitation to share our journey and vision! You can listen to the podcast at the link below: https://lnkd.in/gPsmFWGz #podcast #Epilepsy #Autism #NeurodevelopmentalDiseases

We come to the end of a great second day at the MaxWell Biosystems 4th In-Vitro 2D & 3D Neuronal Networks Summit! And guess what? We've still got one more day packed with innovation and exciting discoveries ahead! 🎉 Our team at NEUROLENTECH GmbH is thrilled to be part of this summit! Plus, we're seizing the opportunity to soak in the breathtaking beauty of Zurich! 🏞️ If you're attending the summit, make sure to connect with our experts, Camilla Bosone and Karin Stecher. They'll be more than happy to share insights on how we seamlessly integrate MaxWell's technology into our day-to-day operations at Neurolentech. 🧠

🚀 The NEUROLENTECH GmbH team is excited to announce our participation in the MaxWell Biosystems 4th In-Vitro 2D & 3D Neuronal Networks Summit! Join us in Zurich, Switzerland from April 8th to 10th. 🧠 Karin Stecher will share insights on "Neurodevelopmental Disease Modelling for Drug Discovery Using Patient-Derived Neuronal Co-Cultures" on Monday, April 8th at 9:45, while Camilla Bosone will present a poster on Tuesday, April 9th at 15:30. If you're curious about Neurolentech's journey towards new treatments for epilepsy and neurodevelopmental disorders, come say Hi! 👋   Learn more about the summit: https://lnkd.in/edyP2ujU   Learn more about Neurolentech: www.neurolentech.com   #MxWSummit2024 #NDD #neuroscience

 🧠 At NEUROLENTECH GmbH we come together to celebrate World Autism Awareness Day! Today, we unite to show our unwavering support and profound appreciation for the incredible contributions of autistic people. 🤝💙 Let's keep the momentum going by spreading awareness and fostering acceptance of autism! 🌍✨   #WorldAutismAwarenessDay #Neurodiversity 

🌟 NEUROLENTECH GmbH is thrilled to announce Fiona Nielsen’s participation in the upcoming Deep Tech Days event in Paris, organized by Hello Tomorrow! 🚀   Fiona will be in Paris for both the Investor Day on March 20th and the Global Summit on March 21st-22nd. During this time, she'll be engaging with deep tech life science investors and diving into the realm of emerging technologies and their immense potential for social and environmental impact.   Don't miss out on this opportunity to connect with Fiona and other industry leaders! Reach out and Fiona will be glad to chat about how NEUROLENTECH GmbH is charting routes to new treatments for epilepsy and neurodevelopmental diseases. 🧠   Find out more about this event here: 👉 https://lnkd.in/dYvtii7r   And more about Neurolentech here: 👉 https://neurolentech.com/     #DeepTechDays #HelloTomorrow #biotech  

🔬 If you see Fiona Nielsen, our CEO, she is always available for a quick chat about NEUROLENTECH GmbH and our ideas for the future of NDD and epilepsy treatments!💡 #womeninscience #biotech #innovation